← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2013Last known activity
Jun 8, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 7 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (12)
- NCT06567522OfficialPhase 4Jun 8, 2024
- NCT06567522Lead sponsorPhase 4Jun 8, 2024
- NCT05283356Lead sponsorPhase 4Jan 21, 2022
- NCT06757751Lead sponsorN/AApr 30, 2021
- NCT06757751Sponsor investigatorN/AApr 30, 2021
- NCT04696185Overall official - principal investigatorPhase 4Jan 7, 2021
- NCT04696185Study chairPhase 4Jan 7, 2021
- NCT04331145Sponsor investigatorPhase 4May 31, 2020
- NCT04331145Overall official - principal investigatorPhase 4May 31, 2020
- NCT04331145Lead sponsorPhase 4May 31, 2020
- NCT05578391Lead sponsorPhase 2Jan 1, 2020
- NCT01642134Overall official - principal investigatorPhase 4Apr 1, 2013
Details
- Last known activity
- Jun 8, 2024